Skip to content
香港聯合腫瘤中心
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Doctor Updates
    • Join us
  • 繁
  • En
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Doctor Updates
    • Join us
  • 繁
  • En

Category: 化驗檢查

NCT06162572: SPLFIO-174 Research

香港聯合腫瘤中心現招募 PD-L1 高表達晚期非小細胞肺癌 (NSCLC) 患者參與 1b/2 期臨床研究 NCT06162572，使用 Cemiplimab 等免疫治療組合，藥物及影像掃瞄費用全免。了解申請資格、研究過程及風險，立即聯絡我們查詢詳情。

立即閱讀
March 10, 2025 No Comments

NCT06564844: TROPION Lung12 Research

A clinical study recruiting patients with stage I non-small cell lung cancer who have completed tumor resection surgery, are ctDNA positive, or have high-risk pathological features

立即閱讀
March 10, 2025 No Comments

NCT06393374: TroFuse-012 Research

The Hong Kong Joint Oncology Centre is now recruiting triple negative breast cancer (TNBC) patients to participate in the Phase 3 clinical study NCT06393374. For those who have not achieved pathological complete response (pCR), MK-2870 combined with Pembrolizumab treatment will be used, with free medication and imaging scanning fees. Get in touch with us immediately to inquire about eligibility, research process, and risks.

立即閱讀
March 10, 2025 No Comments

NCT06312137: TroFuse-019 Research

The Hong Kong Joint Oncology Centre is now recruiting patients with resectable stage II to IIIB (N2) non-small cell lung cancer (NSCLC) to participate in the Phase 3 clinical study NCT06312137, using Pembrolizumab combined with MK-2870 treatment, with free medication and imaging scanning fees. Get in touch with us immediately to inquire about eligibility, research process, and risks.

立即閱讀
February 19, 2025 No Comments

October 21 [Hong Kong Society of Oncology] Special Lecture on "Comprehensive Deconstruction of Lung Cancer"

立即閱讀
October 23, 2024 No Comments
晚期癌症患者的新治療選擇_建議及早安排HER2 蛋白表達的 IHC 免疫組織化學 測試

A new treatment option for patients with advanced cancer! It is recommended to arrange an IHC immunohistochemical test for HER2 protein expression as soon as possible

  在2024年4月5日，FDA對fam-trastuzumab deruxtecan-nxki（品牌名稱Enhertu）授予加速批准，適用

立即閱讀
October 23, 2024 No Comments

My wife is 54 years old and in good spirits. She underwent a second stage rectal tumor resection in June 2019 without follow-up treatment. After the surgery, her CEA index was 3.2; In June 2020, the CEA index rose to 10, and it was discovered that colorectal cancer had metastasized to the liver. The first course of treatment (injection of Oxaliplatin plus oral Xeloda for two weeks) began on June 26, and then the patient was transferred to a public hospital for targeted therapy and chemotherapy. The patient completed the first targeted therapy with Cetuximab and the second chemotherapy with Oxaliplatin (Eloxatin), Fluorouracil (5FU), and Folinic Acid on 15/7. I should be readmitted for further treatment in two weeks. On July 27th, a blood test was taken. Due to low platelet count and high liver enzymes, another blood test was needed on August 3rd, one week later, to determine whether I could continue chemotherapy. Unfortunately, on August 4th, I saw a doctor who said that the blood test results showed a platelet index of 0.8 and liver enzymes were three times normal. Therefore, I have not been able to start the second targeted therapy and the third chemotherapy. It depends on the blood test results on August 10th to know whether I can start the next course of treatment. That is, the third chemotherapy has been delayed for three weeks. The current question is that my wife's CEA index of 3.3 has decreased compared to before chemotherapy. However, if the blood test results continue to be unsatisfactory and treatment is delayed, will it have an impact on her condition and drug resistance? Also, may I ask how to increase platelets and decrease liver enzyme index during this period? Teach with effort!

Oxaliplatin 的化療藥常見令到血小板低，如果想保持藥量而不影響其功效， 可考慮由每三星期一次的化療藥，轉為兩星期一次療程的方案（保留 Oxa

立即閱讀
October 23, 2024 No Comments

I was diagnosed with stage III nasopharyngeal carcinoma in mid March this year. After more than 30 rounds of electrotherapy and five rounds of chemotherapy, I completed the course of treatment on June 11th. But at the end of July, I did a PET scan and found a tumor in the third section above the caudal keel. When arranging for electrotherapy, I asked the doctor why only palliative electrotherapy was used. He told me that because my cancer had spread into the bone, there was no chance of cure! Is that the case? Also, I saw another private doctor who told me that currently only immunotherapy can be tried, but due to the high cost of medical treatment, he is unsure if he can help me with the treatment. May I ask if this is the only method that can be tried in this situation? Please note that I am 52 years old

三十多次電療及五次化療是屬於根治性質的治療方案。 如果正電子掃描 PET-CT 只發現一處擴散位置的話， 我們稱之為「寡轉移」。 這有可能只是唯一擴散

立即閱讀
2024 年 10 月 22 日 No Comments
Headline Daily_基因檢測識破肺癌病因 配對精準藥物一線治療 助提升療效

Headline Daily_genic testing to see through the etiology of lung cancer, matching precision drugs, first-line treatment to help improve the efficacy

Headline Daily_genic testing to see through the etiology of lung cancer, matching precision drugs, first-line treatment to help improve the efficacy

立即閱讀
October 17, 2024 No Comments
AM730_MET肺癌標靶治療 提升緩解機會

AM730_MET targeted treatment for lung cancer improves chance of remission

AM730_MET targeted treatment for lung cancer improves chance of remission

立即閱讀
October 17, 2024 No Comments
Page1 Page2 Page3 Page4 Page5
香港聯合腫瘤中心

The Hong Kong United Oncology Centre (HKUOC) provides cancer-related medical services such as cancer screening, cancer diagnosis and cancer treatment, including immunotherapy, chemotherapy, targeted drug therapy, radiation therapy, hormone therapy and palliative care.

Contact us

  • Address: Rooms 01-06, 20/F, 238 Nathan Road, Kowloon (MTR Jordan Station Exit E)
  • Phone: +852 2386 8002
  • WhatsApp：5518 2992
  • Fax: (852) 2386 8229
  • Macau: Enquiry@hkuoc.hk

Consultation time

Monday to Friday

9:00 am to 1:00 pm

2:00 p.m. to 6:00 p.m.

Saturday

9:00 am to 1:00 pm

Closed on Sundays and public holidays

Types of cancer

  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer
  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer

Cancer treatment

  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy
  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy

phone

WhatsApp

Facebook